GMEB1 and neuroblastoma: Furthermore, we determined the prognostic effects of ALCAM, BTBD9, CACNA2D3, DST, EPB41L4A, FGD6, GMEB1, IGSF3 and KIF1B in MYCN non-amplified neuroblastoma patients.